OGEN - MCAP CO - Oragenics, Inc.

Oragenics, Inc. (OGEN) develops innovative nasal products at its US centers, leveraging unique delivery methods. The business model focuses on monetizing patents through global licenses, which minimizes capital expenditures. The company is currently penetrating the concussion therapy niche, where no equivalents exist. The current metric stands at 0.00, and the price chart below visualizes the asset's market dynamics.

Oragenics, Inc. (OGEN) strategic alliance with state vaccine centers establishes the foundation for long-term business value. This value is mathematically expressed through market capitalization, calculated as the product of the total number of shares and their current price. This indicator determines the aggregate market value of all the issuer's outstanding securities. By analyzing the current capitalization level of Oragenics, Inc. (OGEN), an investor can filter out short-term market noise. The dynamics of this metric reflect the market's actual confidence in the company's scientific developments.